7H7-30333-59205
2 vaccinations
2 coded responses
16 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 290 / SC
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-18
Dose 1 — Pfizer-BioNTech
-
2021-01-19
Registered in v-safe
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-02-01
-
2021-02-08
Dose 2 — Pfizer-BioNTech
-
2021-02-11
Survey response — days 1–6 daily, dose 2MedDRA: Nasopharyngitis — Feeling: Good · Site: Pain · Headache, Muscle or body achesFree text: Head coldMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Survey response — days 1–6 daily, dose 2MedDRA: Sinusitis — Feeling: Fair · HeadacheFree text: Sinus infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-13
- 2021-02-15
- 2021-02-22
- 2021-03-03
- 2021-03-08
- 2021-03-17
- 2021-03-22
- 2021-05-12
- 2021-08-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Pfizer-BioNTech | |
| 2 | 2021-02-08 | Pfizer-BioNTech |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Head cold
Systemic reaction (other): Sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Nasopharyngitis | ✓ | ✓ | ✓ |
| SRO | Sinusitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release